Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.
Amelie de GregorioLothar HäberlePeter A FaschingVolkmar MüllerIris SchraderRalf LorenzHelmut ForstbauerThomas W P FriedlEmanuel BauerNikolaus de GregorioMiriam DenizVisnja FinkInga BekesUlrich AndergassenAndreas SchneeweissHans TeschSven MahnerSara Y BruckerJens-Uwe BlohmerTanja N FehmGeorg HeinrichKrisztian LatoMatthias W BeckmannBrigitte RackWolfgang JanniPublished in: Breast cancer research : BCR (2020)
Clinicaltrials.gov NCT02181101 and EU Clinical Trials Register EudraCT 2005-000490-21. Registered September 2005.